SlideShare a Scribd company logo
• DEFINITION
• INTRODUCTION
• AIM
• BODY RHYTHMS
• CIRCADIAN RHYTHMS
• CLASSIFICATION
• FACTORS EFFECTING CIRCADIAN RHYTHMS
• DRUGS THAT UNDERGO CHRONOKINETICS
• CHRONOTHERAPEUTIC DRUG DELIVERY SYSTEMS
• LIMITATIONS
• APPLICATIONS
• CONCLUSION
• Chronopharmacokinetics investigates the variation in drug
plasma levels as a function of time of day and the mechanisms
responsible for time dependent variations.
• It deals with the study of the temporal changes in absorption,
distribution, metabolism and elimination.
• Drug Absorption, Distribution, Metabolism and Elimination
are influenced by many different physiological functions
of the body which may vary with time.
• Hence the time of the day has to be regarded as an
additional variable influencing the kinetics of a drug.
• The time of administration is a possible factor of variation
in the kinetics of a drug.
• The main aim is to know the moment of administration of
drug to achieve desired drug plasma concentration so as to
eliminate chances of discomfort felt by the patient due to the
higher intensity of symptoms of a disease for which drug
therapy is required.
• These studies also aim to administer drugs at an optimum
time so that the resulting drug plasma concentrations are
either or least toxic or totally safe for body.
• These are the biological process that show cyclic
variations over time.
• Types of body rhythms:
 Circadian Rhythms :which lasts for about one day.
Ex : Sleep walking, body temperature.
 Ultradian Rhythms: which lasts for shorter than a day, like
seconds. Ex: heartbeat
 Infradian Rhythms :which lasts for longer than a day, like
monthly rhythms- menstrual cycle
Sleep cycle
Sleep cycle
• brain
• It is altered by circadian changes in
gastric emptying time
gastrointestinal blood flow
gastric acid secretion and pH
• Most lipophilic drugs seem to be absorbed faster when the
drug is taken in the morning compared with the evening.
Ex: absorption in valproic acid larger in the morning than in
the evening.
• It is altered by circadian changes in
body size and composition
blood flow to various organs
drug protein binding
Peak plasma concentration of plasma proteins like
albumin occurs early in the afternoon, while troughs are found
during .
Ex: Maximum binding of neoplastics like cisplastin to
plasma proteins is in the afternoon and minimum in the
morning.
• It is altered by circadian changes in liver enzyme activity,
hepatic blood flow.
• For drugs with low extraction ratio depends on liver enzyme
activity.
• For drugs with extraction ratio depends on hepatic blood flow.
• It is altered by circadian changes in
Glomerular filtration
Renal blood flow
Urinary pH
Tubular reabsorption
• All lower during the resting period than in activity period
Ex: acidic drugs like sodium salicylate excreted quickly
after evening than morning administration.
 CIRCARDIAN CHANGES IN DRUG ABSORPTION
It is altered due to changes in
• Gastric acid secretion
• pH
• Motility
• Gastric emptying time-longer for evening meal - Tmax
• Gl blood flow
• Routes of administration
• Absorption is also altered due to physicochemical properties-
lipophilicity or hydrophilicity.
• Ex:
Most lipophilic drugs like phenytoin seems to be absorbed faster
when the drug is taken in morning compared with the evening.
• Distribution is altered due to circadian changes in:
• Body size and composition
• Blood flow to organs
• Plasma protein binding
• Membrane permeability to drugs
Peak plasma concentration of plasma proteins like albumin
and 1- glycoprotein are time dependent and occurs early in the
afternoon when compared during the night.
Ex:
Drug concentration of free fraction of phenytoin and
valproic acid have been found to vary in 24 hrs scale.
Metabolism is altered due to circadian changes in
• Liver
• Cytochrome P-450 monooxygenase ex: beta hydrocortisol
• Hepatic blood flow
• First pass elimination of drugs
• Enzyme activity
• Temporal variation in oxidase activity of the liver and
concentration of microsomal enzyme at the beginning of
activity.
• Temporal variations in conjugation i.e., hepatic
glucuronidation and sulfation. Ex: paracetamol
• Systemic clearance decreases at night and increases during day
time.
• For drugs with low extraction ratios fluctuations in intrinsic
metabolic clearance in plasma protein binding.
• Ex: valproic acid, clonazepam.
Excretion is altered due to circadian changes in:
• Glomerular filtration
• Renal blood flow
• Urinary pH
• Tubular reabsorption
• Urine output
• Urinary excretion of electrolytes.
All these are lowered during the resting period than in activity
period.
• The drug concentration will be maximum during the dark
period (2:00 A.M-5:00 A.M)
• It will be minimum during the light period (14:00 PM-17:00
PM)
Induction of enzymes by the drug is responsible for elimination
there by increase the clearance of the drug.
Ex: Repeated doses of carbamazepine ,rifampicin induces the
enzymes reponsible for their elimination.
The metabolites formed increase in concentration and further
inhibit metabolism of the parent drug.
Ex: xanthine oxidase inhibitor-allopurinal,verapamil.
• Food
• Meal timing
• GI pH
• Intestinal motility
• Digestive secretions
• Intestinal blood flow
• Light
• The timing of exposure to light
• The length of exposure to light
• Intensity and wavelength of light
• Antibiotics-aminoglycosides
• Anti hypertensive drugs-propranolol,nifidipine
• Anti epileptic drugs-valproic acid
• Anti cancer drug-cyclosporine,methotrexate
• NSAIDS –Ketoprofen,indomethacin
• Enteric coatings
• Layered systems
• Time controlled explosion systems (TES)
• Sigmoidal release systems (SRS)
• Press coated systems
• Difference between species-rodents and humans
• Harmful to rodents/experimental animal
• Large number of animals
• Very complex anti-cancer drug development
• ASTHMA
Ex: Theophylline
• GASTRO INTESTINAL DISEASES
Ex: Ranitidine
• ARTHRITIS
Ex: Ibuprofen
• CARDIO VASULAR DISEASES
• CANCER
• The concept of drug treatment was earlier “right drug for the
right person’’ is now changed to “right dose for the right
person at right time”.
• Time dependent pharmacokinetics can sometimes be
responsible for daily variation drug effects or adverse effects.
• Hence time of the day should be considered as an additional
variable that influences the kinetics of the drug.
Chronopharmacokinetics (final)   copy

More Related Content

What's hot

Controlled and sustained release dosage form/CONTROLLED RELEASE DOSAGE FORM/S...
Controlled and sustained release dosage form/CONTROLLED RELEASE DOSAGE FORM/S...Controlled and sustained release dosage form/CONTROLLED RELEASE DOSAGE FORM/S...
Controlled and sustained release dosage form/CONTROLLED RELEASE DOSAGE FORM/S...
Ashwani Kumar Singh
 
permeation enhancers by Hemant Chalaune ist M pharm
permeation enhancers by  Hemant Chalaune ist  M pharm permeation enhancers by  Hemant Chalaune ist  M pharm
permeation enhancers by Hemant Chalaune ist M pharm
Gaule Jeevan
 
M pharm dissolution
M pharm dissolutionM pharm dissolution
M pharm dissolution
Malla Reddy College of Pharmacy
 
Intranasal drug delivery system
Intranasal drug delivery systemIntranasal drug delivery system
Intranasal drug delivery system
Alexa Jacob
 
Dissolution testing
Dissolution testingDissolution testing
Dissolution testing
Gaurav Kr
 
FORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGS
FORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGSFORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGS
FORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGS
N Anusha
 
Dissolution method and ivivc by ranjeet singh
Dissolution method and ivivc by ranjeet singhDissolution method and ivivc by ranjeet singh
Dissolution method and ivivc by ranjeet singh
Ranjeet Singh
 
Microencapsulation
MicroencapsulationMicroencapsulation
TRANSDERMAL DRUG DELIVERY SYSTEM
TRANSDERMAL DRUG DELIVERY SYSTEMTRANSDERMAL DRUG DELIVERY SYSTEM
TRANSDERMAL DRUG DELIVERY SYSTEM
Dr Gajanan Sanap
 
Microspheres - Methods for Preparation of Microspheres
Microspheres - Methods for Preparation of MicrospheresMicrospheres - Methods for Preparation of Microspheres
Microspheres - Methods for Preparation of Microspheres
Sagar Savale
 
Compendial methods of dissolution testing
Compendial methods of dissolution testing Compendial methods of dissolution testing
Compendial methods of dissolution testing
Nagaraju Ravouru
 
Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...
Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...
Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...
PRAJAKTASAWANT33
 
Solid dispersion
Solid dispersionSolid dispersion
Solid dispersion
Anita Duduskar
 
solid dispersion
solid dispersionsolid dispersion
solid dispersion
ceutics1315
 
Controlled release drug delivery system
Controlled release drug delivery system Controlled release drug delivery system
Controlled release drug delivery system
MOHAMMEDABDULSALAM32
 
Buccal Drug Delivery System
Buccal Drug Delivery SystemBuccal Drug Delivery System
Buccal Drug Delivery System
MOHAMMAD ASIM
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery system
Arshad Khan
 
Oral sustained and controlled release dosage forms
Oral sustained and controlled release dosage forms Oral sustained and controlled release dosage forms
Oral sustained and controlled release dosage forms
Dr Gajanan Sanap
 
Controlled drug delivery system
Controlled drug delivery systemControlled drug delivery system
Controlled drug delivery system
Srushti Chahande
 
Chronopharmacokinetics
ChronopharmacokineticsChronopharmacokinetics
Chronopharmacokinetics
lamar university, beaumont texas
 

What's hot (20)

Controlled and sustained release dosage form/CONTROLLED RELEASE DOSAGE FORM/S...
Controlled and sustained release dosage form/CONTROLLED RELEASE DOSAGE FORM/S...Controlled and sustained release dosage form/CONTROLLED RELEASE DOSAGE FORM/S...
Controlled and sustained release dosage form/CONTROLLED RELEASE DOSAGE FORM/S...
 
permeation enhancers by Hemant Chalaune ist M pharm
permeation enhancers by  Hemant Chalaune ist  M pharm permeation enhancers by  Hemant Chalaune ist  M pharm
permeation enhancers by Hemant Chalaune ist M pharm
 
M pharm dissolution
M pharm dissolutionM pharm dissolution
M pharm dissolution
 
Intranasal drug delivery system
Intranasal drug delivery systemIntranasal drug delivery system
Intranasal drug delivery system
 
Dissolution testing
Dissolution testingDissolution testing
Dissolution testing
 
FORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGS
FORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGSFORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGS
FORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGS
 
Dissolution method and ivivc by ranjeet singh
Dissolution method and ivivc by ranjeet singhDissolution method and ivivc by ranjeet singh
Dissolution method and ivivc by ranjeet singh
 
Microencapsulation
MicroencapsulationMicroencapsulation
Microencapsulation
 
TRANSDERMAL DRUG DELIVERY SYSTEM
TRANSDERMAL DRUG DELIVERY SYSTEMTRANSDERMAL DRUG DELIVERY SYSTEM
TRANSDERMAL DRUG DELIVERY SYSTEM
 
Microspheres - Methods for Preparation of Microspheres
Microspheres - Methods for Preparation of MicrospheresMicrospheres - Methods for Preparation of Microspheres
Microspheres - Methods for Preparation of Microspheres
 
Compendial methods of dissolution testing
Compendial methods of dissolution testing Compendial methods of dissolution testing
Compendial methods of dissolution testing
 
Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...
Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...
Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...
 
Solid dispersion
Solid dispersionSolid dispersion
Solid dispersion
 
solid dispersion
solid dispersionsolid dispersion
solid dispersion
 
Controlled release drug delivery system
Controlled release drug delivery system Controlled release drug delivery system
Controlled release drug delivery system
 
Buccal Drug Delivery System
Buccal Drug Delivery SystemBuccal Drug Delivery System
Buccal Drug Delivery System
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery system
 
Oral sustained and controlled release dosage forms
Oral sustained and controlled release dosage forms Oral sustained and controlled release dosage forms
Oral sustained and controlled release dosage forms
 
Controlled drug delivery system
Controlled drug delivery systemControlled drug delivery system
Controlled drug delivery system
 
Chronopharmacokinetics
ChronopharmacokineticsChronopharmacokinetics
Chronopharmacokinetics
 

Similar to Chronopharmacokinetics (final) copy

Bioavailability of drgs that follow nonlinear pharmacokinetics
Bioavailability of drgs that follow nonlinear pharmacokineticsBioavailability of drgs that follow nonlinear pharmacokinetics
Bioavailability of drgs that follow nonlinear pharmacokinetics
Malla Reddy College of Pharmacy
 
chronokinetics, Chronotherapeutics and chronomodulated drug delivery system
chronokinetics, Chronotherapeutics and chronomodulated drug delivery systemchronokinetics, Chronotherapeutics and chronomodulated drug delivery system
chronokinetics, Chronotherapeutics and chronomodulated drug delivery system
Revathi Reddy
 
Chronopharmacokinetics
ChronopharmacokineticsChronopharmacokinetics
Chronopharmacokinetics
Samatha Jajala
 
Chronopharmacology
ChronopharmacologyChronopharmacology
Chronopharmacology
SameerKhasbage
 
Drugexcretion 130121005834-phpapp01
Drugexcretion 130121005834-phpapp01Drugexcretion 130121005834-phpapp01
Drugexcretion 130121005834-phpapp01
suhasini
 
Ace Your NAPLEX Exam: Master Kinetics, DDI, and Pharmacogenomics in Lecture 2!
Ace Your NAPLEX Exam: Master Kinetics, DDI, and Pharmacogenomics in Lecture 2!Ace Your NAPLEX Exam: Master Kinetics, DDI, and Pharmacogenomics in Lecture 2!
Ace Your NAPLEX Exam: Master Kinetics, DDI, and Pharmacogenomics in Lecture 2!
Jackson Wang
 
Chrono pharmacokinetics
Chrono pharmacokineticsChrono pharmacokinetics
Chrono pharmacokinetics
ankit
 
Pharmacokinetics-2
Pharmacokinetics-2Pharmacokinetics-2
Pharmacokinetics-2
Dr ABOOBECKER SIDDIQUE P.A
 
Drug excretion
Drug  excretionDrug  excretion
Drug excretion
suniu
 
SEMINAR1 ON EXCRETION OF DRUGS final.pptx
SEMINAR1 ON EXCRETION OF DRUGS final.pptxSEMINAR1 ON EXCRETION OF DRUGS final.pptx
SEMINAR1 ON EXCRETION OF DRUGS final.pptx
DrMadanChandraDas
 
Renal elimination.pdf fffffffffffffffffffff
Renal elimination.pdf fffffffffffffffffffffRenal elimination.pdf fffffffffffffffffffff
Renal elimination.pdf fffffffffffffffffffff
RehanRustam2
 
Chronopharmacology
ChronopharmacologyChronopharmacology
Chronopharmacology
Dr Ramesh Krishnan
 
Pharmacodynamics in pregnancy and placenta.pptx
Pharmacodynamics in pregnancy and placenta.pptxPharmacodynamics in pregnancy and placenta.pptx
Pharmacodynamics in pregnancy and placenta.pptx
Indunil Piyadigama
 
Renal drug excretion
Renal drug excretionRenal drug excretion
Renal drug excretion
amina tariq
 
PHARMACOKINETICS.pptx
PHARMACOKINETICS.pptxPHARMACOKINETICS.pptx
PHARMACOKINETICS.pptx
Ajeem Mohamed
 
ELIMIMATION OF DRUGS [YOGESH YADAV].pptx
ELIMIMATION OF DRUGS [YOGESH YADAV].pptxELIMIMATION OF DRUGS [YOGESH YADAV].pptx
ELIMIMATION OF DRUGS [YOGESH YADAV].pptx
yogesh532361
 
Drug excretion -DM WIMS -7-04-22.pptx
Drug excretion -DM WIMS -7-04-22.pptxDrug excretion -DM WIMS -7-04-22.pptx
Drug excretion -DM WIMS -7-04-22.pptx
RaviMundugaru1
 
Membrane transport and absorption
Membrane transport and absorptionMembrane transport and absorption
Membrane transport and absorption
Harikrishnan A R
 
Pharmacokinetics-4_033758.pptx
Pharmacokinetics-4_033758.pptxPharmacokinetics-4_033758.pptx
Pharmacokinetics-4_033758.pptx
EmmanuelOluseyi1
 
PKPD NEW.pptx
PKPD NEW.pptxPKPD NEW.pptx
PKPD NEW.pptx
ssuser3c47e3
 

Similar to Chronopharmacokinetics (final) copy (20)

Bioavailability of drgs that follow nonlinear pharmacokinetics
Bioavailability of drgs that follow nonlinear pharmacokineticsBioavailability of drgs that follow nonlinear pharmacokinetics
Bioavailability of drgs that follow nonlinear pharmacokinetics
 
chronokinetics, Chronotherapeutics and chronomodulated drug delivery system
chronokinetics, Chronotherapeutics and chronomodulated drug delivery systemchronokinetics, Chronotherapeutics and chronomodulated drug delivery system
chronokinetics, Chronotherapeutics and chronomodulated drug delivery system
 
Chronopharmacokinetics
ChronopharmacokineticsChronopharmacokinetics
Chronopharmacokinetics
 
Chronopharmacology
ChronopharmacologyChronopharmacology
Chronopharmacology
 
Drugexcretion 130121005834-phpapp01
Drugexcretion 130121005834-phpapp01Drugexcretion 130121005834-phpapp01
Drugexcretion 130121005834-phpapp01
 
Ace Your NAPLEX Exam: Master Kinetics, DDI, and Pharmacogenomics in Lecture 2!
Ace Your NAPLEX Exam: Master Kinetics, DDI, and Pharmacogenomics in Lecture 2!Ace Your NAPLEX Exam: Master Kinetics, DDI, and Pharmacogenomics in Lecture 2!
Ace Your NAPLEX Exam: Master Kinetics, DDI, and Pharmacogenomics in Lecture 2!
 
Chrono pharmacokinetics
Chrono pharmacokineticsChrono pharmacokinetics
Chrono pharmacokinetics
 
Pharmacokinetics-2
Pharmacokinetics-2Pharmacokinetics-2
Pharmacokinetics-2
 
Drug excretion
Drug  excretionDrug  excretion
Drug excretion
 
SEMINAR1 ON EXCRETION OF DRUGS final.pptx
SEMINAR1 ON EXCRETION OF DRUGS final.pptxSEMINAR1 ON EXCRETION OF DRUGS final.pptx
SEMINAR1 ON EXCRETION OF DRUGS final.pptx
 
Renal elimination.pdf fffffffffffffffffffff
Renal elimination.pdf fffffffffffffffffffffRenal elimination.pdf fffffffffffffffffffff
Renal elimination.pdf fffffffffffffffffffff
 
Chronopharmacology
ChronopharmacologyChronopharmacology
Chronopharmacology
 
Pharmacodynamics in pregnancy and placenta.pptx
Pharmacodynamics in pregnancy and placenta.pptxPharmacodynamics in pregnancy and placenta.pptx
Pharmacodynamics in pregnancy and placenta.pptx
 
Renal drug excretion
Renal drug excretionRenal drug excretion
Renal drug excretion
 
PHARMACOKINETICS.pptx
PHARMACOKINETICS.pptxPHARMACOKINETICS.pptx
PHARMACOKINETICS.pptx
 
ELIMIMATION OF DRUGS [YOGESH YADAV].pptx
ELIMIMATION OF DRUGS [YOGESH YADAV].pptxELIMIMATION OF DRUGS [YOGESH YADAV].pptx
ELIMIMATION OF DRUGS [YOGESH YADAV].pptx
 
Drug excretion -DM WIMS -7-04-22.pptx
Drug excretion -DM WIMS -7-04-22.pptxDrug excretion -DM WIMS -7-04-22.pptx
Drug excretion -DM WIMS -7-04-22.pptx
 
Membrane transport and absorption
Membrane transport and absorptionMembrane transport and absorption
Membrane transport and absorption
 
Pharmacokinetics-4_033758.pptx
Pharmacokinetics-4_033758.pptxPharmacokinetics-4_033758.pptx
Pharmacokinetics-4_033758.pptx
 
PKPD NEW.pptx
PKPD NEW.pptxPKPD NEW.pptx
PKPD NEW.pptx
 

Recently uploaded

Methods of grain storage Structures in India.pdf
Methods of grain storage Structures in India.pdfMethods of grain storage Structures in India.pdf
Methods of grain storage Structures in India.pdf
PirithiRaju
 
TOPIC OF DISCUSSION: CENTRIFUGATION SLIDESHARE.pptx
TOPIC OF DISCUSSION: CENTRIFUGATION SLIDESHARE.pptxTOPIC OF DISCUSSION: CENTRIFUGATION SLIDESHARE.pptx
TOPIC OF DISCUSSION: CENTRIFUGATION SLIDESHARE.pptx
shubhijain836
 
The cost of acquiring information by natural selection
The cost of acquiring information by natural selectionThe cost of acquiring information by natural selection
The cost of acquiring information by natural selection
Carl Bergstrom
 
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
vluwdy49
 
Signatures of wave erosion in Titan’s coasts
Signatures of wave erosion in Titan’s coastsSignatures of wave erosion in Titan’s coasts
Signatures of wave erosion in Titan’s coasts
Sérgio Sacani
 
Clinical periodontology and implant dentistry 2003.pdf
Clinical periodontology and implant dentistry 2003.pdfClinical periodontology and implant dentistry 2003.pdf
Clinical periodontology and implant dentistry 2003.pdf
RAYMUNDONAVARROCORON
 
Anti-Universe And Emergent Gravity and the Dark Universe
Anti-Universe And Emergent Gravity and the Dark UniverseAnti-Universe And Emergent Gravity and the Dark Universe
Anti-Universe And Emergent Gravity and the Dark Universe
Sérgio Sacani
 
2001_Book_HumanChromosomes - Genéticapdf
2001_Book_HumanChromosomes - Genéticapdf2001_Book_HumanChromosomes - Genéticapdf
2001_Book_HumanChromosomes - Genéticapdf
lucianamillenium
 
Mechanisms and Applications of Antiviral Neutralizing Antibodies - Creative B...
Mechanisms and Applications of Antiviral Neutralizing Antibodies - Creative B...Mechanisms and Applications of Antiviral Neutralizing Antibodies - Creative B...
Mechanisms and Applications of Antiviral Neutralizing Antibodies - Creative B...
Creative-Biolabs
 
Evidence of Jet Activity from the Secondary Black Hole in the OJ 287 Binary S...
Evidence of Jet Activity from the Secondary Black Hole in the OJ 287 Binary S...Evidence of Jet Activity from the Secondary Black Hole in the OJ 287 Binary S...
Evidence of Jet Activity from the Secondary Black Hole in the OJ 287 Binary S...
Sérgio Sacani
 
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...
Scintica Instrumentation
 
Immersive Learning That Works: Research Grounding and Paths Forward
Immersive Learning That Works: Research Grounding and Paths ForwardImmersive Learning That Works: Research Grounding and Paths Forward
Immersive Learning That Works: Research Grounding and Paths Forward
Leonel Morgado
 
Discovery of An Apparent Red, High-Velocity Type Ia Supernova at 𝐳 = 2.9 wi...
Discovery of An Apparent Red, High-Velocity Type Ia Supernova at  𝐳 = 2.9  wi...Discovery of An Apparent Red, High-Velocity Type Ia Supernova at  𝐳 = 2.9  wi...
Discovery of An Apparent Red, High-Velocity Type Ia Supernova at 𝐳 = 2.9 wi...
Sérgio Sacani
 
LEARNING TO LIVE WITH LAWS OF MOTION .pptx
LEARNING TO LIVE WITH LAWS OF MOTION .pptxLEARNING TO LIVE WITH LAWS OF MOTION .pptx
LEARNING TO LIVE WITH LAWS OF MOTION .pptx
yourprojectpartner05
 
SDSS1335+0728: The awakening of a ∼ 106M⊙ black hole⋆
SDSS1335+0728: The awakening of a ∼ 106M⊙ black hole⋆SDSS1335+0728: The awakening of a ∼ 106M⊙ black hole⋆
SDSS1335+0728: The awakening of a ∼ 106M⊙ black hole⋆
Sérgio Sacani
 
Physiology of Nervous System presentation.pptx
Physiology of Nervous System presentation.pptxPhysiology of Nervous System presentation.pptx
Physiology of Nervous System presentation.pptx
fatima132662
 
Candidate young stellar objects in the S-cluster: Kinematic analysis of a sub...
Candidate young stellar objects in the S-cluster: Kinematic analysis of a sub...Candidate young stellar objects in the S-cluster: Kinematic analysis of a sub...
Candidate young stellar objects in the S-cluster: Kinematic analysis of a sub...
Sérgio Sacani
 
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdfMending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
Selcen Ozturkcan
 
Farming systems analysis: what have we learnt?.pptx
Farming systems analysis: what have we learnt?.pptxFarming systems analysis: what have we learnt?.pptx
Farming systems analysis: what have we learnt?.pptx
Frédéric Baudron
 
GBSN - Biochemistry (Unit 6) Chemistry of Proteins
GBSN - Biochemistry (Unit 6) Chemistry of ProteinsGBSN - Biochemistry (Unit 6) Chemistry of Proteins
GBSN - Biochemistry (Unit 6) Chemistry of Proteins
Areesha Ahmad
 

Recently uploaded (20)

Methods of grain storage Structures in India.pdf
Methods of grain storage Structures in India.pdfMethods of grain storage Structures in India.pdf
Methods of grain storage Structures in India.pdf
 
TOPIC OF DISCUSSION: CENTRIFUGATION SLIDESHARE.pptx
TOPIC OF DISCUSSION: CENTRIFUGATION SLIDESHARE.pptxTOPIC OF DISCUSSION: CENTRIFUGATION SLIDESHARE.pptx
TOPIC OF DISCUSSION: CENTRIFUGATION SLIDESHARE.pptx
 
The cost of acquiring information by natural selection
The cost of acquiring information by natural selectionThe cost of acquiring information by natural selection
The cost of acquiring information by natural selection
 
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
 
Signatures of wave erosion in Titan’s coasts
Signatures of wave erosion in Titan’s coastsSignatures of wave erosion in Titan’s coasts
Signatures of wave erosion in Titan’s coasts
 
Clinical periodontology and implant dentistry 2003.pdf
Clinical periodontology and implant dentistry 2003.pdfClinical periodontology and implant dentistry 2003.pdf
Clinical periodontology and implant dentistry 2003.pdf
 
Anti-Universe And Emergent Gravity and the Dark Universe
Anti-Universe And Emergent Gravity and the Dark UniverseAnti-Universe And Emergent Gravity and the Dark Universe
Anti-Universe And Emergent Gravity and the Dark Universe
 
2001_Book_HumanChromosomes - Genéticapdf
2001_Book_HumanChromosomes - Genéticapdf2001_Book_HumanChromosomes - Genéticapdf
2001_Book_HumanChromosomes - Genéticapdf
 
Mechanisms and Applications of Antiviral Neutralizing Antibodies - Creative B...
Mechanisms and Applications of Antiviral Neutralizing Antibodies - Creative B...Mechanisms and Applications of Antiviral Neutralizing Antibodies - Creative B...
Mechanisms and Applications of Antiviral Neutralizing Antibodies - Creative B...
 
Evidence of Jet Activity from the Secondary Black Hole in the OJ 287 Binary S...
Evidence of Jet Activity from the Secondary Black Hole in the OJ 287 Binary S...Evidence of Jet Activity from the Secondary Black Hole in the OJ 287 Binary S...
Evidence of Jet Activity from the Secondary Black Hole in the OJ 287 Binary S...
 
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...
 
Immersive Learning That Works: Research Grounding and Paths Forward
Immersive Learning That Works: Research Grounding and Paths ForwardImmersive Learning That Works: Research Grounding and Paths Forward
Immersive Learning That Works: Research Grounding and Paths Forward
 
Discovery of An Apparent Red, High-Velocity Type Ia Supernova at 𝐳 = 2.9 wi...
Discovery of An Apparent Red, High-Velocity Type Ia Supernova at  𝐳 = 2.9  wi...Discovery of An Apparent Red, High-Velocity Type Ia Supernova at  𝐳 = 2.9  wi...
Discovery of An Apparent Red, High-Velocity Type Ia Supernova at 𝐳 = 2.9 wi...
 
LEARNING TO LIVE WITH LAWS OF MOTION .pptx
LEARNING TO LIVE WITH LAWS OF MOTION .pptxLEARNING TO LIVE WITH LAWS OF MOTION .pptx
LEARNING TO LIVE WITH LAWS OF MOTION .pptx
 
SDSS1335+0728: The awakening of a ∼ 106M⊙ black hole⋆
SDSS1335+0728: The awakening of a ∼ 106M⊙ black hole⋆SDSS1335+0728: The awakening of a ∼ 106M⊙ black hole⋆
SDSS1335+0728: The awakening of a ∼ 106M⊙ black hole⋆
 
Physiology of Nervous System presentation.pptx
Physiology of Nervous System presentation.pptxPhysiology of Nervous System presentation.pptx
Physiology of Nervous System presentation.pptx
 
Candidate young stellar objects in the S-cluster: Kinematic analysis of a sub...
Candidate young stellar objects in the S-cluster: Kinematic analysis of a sub...Candidate young stellar objects in the S-cluster: Kinematic analysis of a sub...
Candidate young stellar objects in the S-cluster: Kinematic analysis of a sub...
 
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdfMending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
 
Farming systems analysis: what have we learnt?.pptx
Farming systems analysis: what have we learnt?.pptxFarming systems analysis: what have we learnt?.pptx
Farming systems analysis: what have we learnt?.pptx
 
GBSN - Biochemistry (Unit 6) Chemistry of Proteins
GBSN - Biochemistry (Unit 6) Chemistry of ProteinsGBSN - Biochemistry (Unit 6) Chemistry of Proteins
GBSN - Biochemistry (Unit 6) Chemistry of Proteins
 

Chronopharmacokinetics (final) copy

  • 1.
  • 2. • DEFINITION • INTRODUCTION • AIM • BODY RHYTHMS • CIRCADIAN RHYTHMS • CLASSIFICATION • FACTORS EFFECTING CIRCADIAN RHYTHMS • DRUGS THAT UNDERGO CHRONOKINETICS • CHRONOTHERAPEUTIC DRUG DELIVERY SYSTEMS • LIMITATIONS • APPLICATIONS • CONCLUSION
  • 3. • Chronopharmacokinetics investigates the variation in drug plasma levels as a function of time of day and the mechanisms responsible for time dependent variations. • It deals with the study of the temporal changes in absorption, distribution, metabolism and elimination.
  • 4. • Drug Absorption, Distribution, Metabolism and Elimination are influenced by many different physiological functions of the body which may vary with time. • Hence the time of the day has to be regarded as an additional variable influencing the kinetics of a drug. • The time of administration is a possible factor of variation in the kinetics of a drug.
  • 5. • The main aim is to know the moment of administration of drug to achieve desired drug plasma concentration so as to eliminate chances of discomfort felt by the patient due to the higher intensity of symptoms of a disease for which drug therapy is required. • These studies also aim to administer drugs at an optimum time so that the resulting drug plasma concentrations are either or least toxic or totally safe for body.
  • 6. • These are the biological process that show cyclic variations over time. • Types of body rhythms:  Circadian Rhythms :which lasts for about one day. Ex : Sleep walking, body temperature.  Ultradian Rhythms: which lasts for shorter than a day, like seconds. Ex: heartbeat  Infradian Rhythms :which lasts for longer than a day, like monthly rhythms- menstrual cycle
  • 9.
  • 10. • It is altered by circadian changes in gastric emptying time gastrointestinal blood flow gastric acid secretion and pH • Most lipophilic drugs seem to be absorbed faster when the drug is taken in the morning compared with the evening. Ex: absorption in valproic acid larger in the morning than in the evening.
  • 11. • It is altered by circadian changes in body size and composition blood flow to various organs drug protein binding Peak plasma concentration of plasma proteins like albumin occurs early in the afternoon, while troughs are found during . Ex: Maximum binding of neoplastics like cisplastin to plasma proteins is in the afternoon and minimum in the morning.
  • 12. • It is altered by circadian changes in liver enzyme activity, hepatic blood flow. • For drugs with low extraction ratio depends on liver enzyme activity. • For drugs with extraction ratio depends on hepatic blood flow.
  • 13. • It is altered by circadian changes in Glomerular filtration Renal blood flow Urinary pH Tubular reabsorption • All lower during the resting period than in activity period Ex: acidic drugs like sodium salicylate excreted quickly after evening than morning administration.
  • 14.
  • 15.  CIRCARDIAN CHANGES IN DRUG ABSORPTION It is altered due to changes in • Gastric acid secretion • pH • Motility • Gastric emptying time-longer for evening meal - Tmax • Gl blood flow • Routes of administration • Absorption is also altered due to physicochemical properties- lipophilicity or hydrophilicity. • Ex: Most lipophilic drugs like phenytoin seems to be absorbed faster when the drug is taken in morning compared with the evening.
  • 16. • Distribution is altered due to circadian changes in: • Body size and composition • Blood flow to organs • Plasma protein binding • Membrane permeability to drugs Peak plasma concentration of plasma proteins like albumin and 1- glycoprotein are time dependent and occurs early in the afternoon when compared during the night. Ex: Drug concentration of free fraction of phenytoin and valproic acid have been found to vary in 24 hrs scale.
  • 17. Metabolism is altered due to circadian changes in • Liver • Cytochrome P-450 monooxygenase ex: beta hydrocortisol • Hepatic blood flow • First pass elimination of drugs • Enzyme activity • Temporal variation in oxidase activity of the liver and concentration of microsomal enzyme at the beginning of activity. • Temporal variations in conjugation i.e., hepatic glucuronidation and sulfation. Ex: paracetamol
  • 18. • Systemic clearance decreases at night and increases during day time. • For drugs with low extraction ratios fluctuations in intrinsic metabolic clearance in plasma protein binding. • Ex: valproic acid, clonazepam. Excretion is altered due to circadian changes in: • Glomerular filtration • Renal blood flow • Urinary pH • Tubular reabsorption • Urine output • Urinary excretion of electrolytes. All these are lowered during the resting period than in activity period.
  • 19. • The drug concentration will be maximum during the dark period (2:00 A.M-5:00 A.M) • It will be minimum during the light period (14:00 PM-17:00 PM)
  • 20. Induction of enzymes by the drug is responsible for elimination there by increase the clearance of the drug. Ex: Repeated doses of carbamazepine ,rifampicin induces the enzymes reponsible for their elimination. The metabolites formed increase in concentration and further inhibit metabolism of the parent drug. Ex: xanthine oxidase inhibitor-allopurinal,verapamil.
  • 21. • Food • Meal timing • GI pH • Intestinal motility • Digestive secretions • Intestinal blood flow • Light • The timing of exposure to light • The length of exposure to light • Intensity and wavelength of light
  • 22. • Antibiotics-aminoglycosides • Anti hypertensive drugs-propranolol,nifidipine • Anti epileptic drugs-valproic acid • Anti cancer drug-cyclosporine,methotrexate • NSAIDS –Ketoprofen,indomethacin
  • 23. • Enteric coatings • Layered systems • Time controlled explosion systems (TES) • Sigmoidal release systems (SRS) • Press coated systems
  • 24.
  • 25. • Difference between species-rodents and humans • Harmful to rodents/experimental animal • Large number of animals • Very complex anti-cancer drug development
  • 26. • ASTHMA Ex: Theophylline • GASTRO INTESTINAL DISEASES Ex: Ranitidine • ARTHRITIS Ex: Ibuprofen • CARDIO VASULAR DISEASES • CANCER
  • 27. • The concept of drug treatment was earlier “right drug for the right person’’ is now changed to “right dose for the right person at right time”. • Time dependent pharmacokinetics can sometimes be responsible for daily variation drug effects or adverse effects. • Hence time of the day should be considered as an additional variable that influences the kinetics of the drug.